Cargando…
Identifying Glioblastoma Gene Networks Based on Hypergeometric Test Analysis
Patient specific therapy is emerging as an important possibility for many cancer patients. However, to identify such therapies it is essential to determine the genomic and transcriptional alterations present in one tumor relative to control samples. This presents a challenge since use of a single sa...
Autores principales: | Stathias, Vasileios, Pastori, Chiara, Griffin, Tess Z., Komotar, Ricardo, Clarke, Jennifer, Zhang, Ming, Ayad, Nagi G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281219/ https://www.ncbi.nlm.nih.gov/pubmed/25551752 http://dx.doi.org/10.1371/journal.pone.0115842 |
Ejemplares similares
-
Epigenetic pathways and glioblastoma treatment
por: Clarke, Jennifer, et al.
Publicado: (2013) -
Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme
por: Tan, Sze Kiat, et al.
Publicado: (2018) -
Drug and disease signature integration identifies synergistic combinations in glioblastoma
por: Stathias, Vasileios, et al.
Publicado: (2018) -
BET bromodomain proteins are required for glioblastoma cell proliferation
por: Pastori, Chiara, et al.
Publicado: (2014) -
Hypergeometric functions and their applications /
por: Seaborn, James B.
Publicado: (1991)